Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder

Int J Mol Sci. 2022 Oct 27;23(21):13054. doi: 10.3390/ijms232113054.

Abstract

Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder that can diminish the quality of life of both children and adults in academic, occupational, and social contexts. The kynurenine pathway (KP) contains a set of enzymatic reactions involved in tryptophan (TRP) degradation. It is known to be associated with the risk of developing ADHD. This review will address the KP and underlying mechanism of inflammation in ADHD. Potential inflammatory biomarkers reported in the most recent studies are summarized. Although a strong neuroimmunological basis has been established due to the advances of recent neurobiological research, the pathophysiology of ADHD remains unclear.

Keywords: ADHD; inflammation; inflammatory biomarkers; kynurenine; kynurenine pathway; neurobiology.

Publication types

  • Review

MeSH terms

  • Adult
  • Attention Deficit Disorder with Hyperactivity*
  • Biomarkers
  • Child
  • Humans
  • Kynurenine / metabolism
  • Neuroimmunomodulation
  • Quality of Life

Substances

  • Kynurenine
  • Biomarkers